Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 6, 2018 | Kedalion Therapeutics | $5.0M Series A | Mark Blumenkranz | — |
| Jul 1, 2018 | Verana Health | $30.0M Series C | GV | ARCH Venture Partners, Define Ventures, Foresite Capital, Gigascale Capital, Jetstream, Khosla Ventures, Kleiner Perkins, Obvious Ventures, VZVC, Marc Benioff, William Miller, Brook Byers, Biomatics Capital, GE Ventures |
| Mar 1, 2018 | ViewPoint Therapeutics | $35.0M Series B | — | Novo Ventures, Ed Hurwitz, BVF Partners, Mission Bay Capital, University of Michigan |
| May 6, 2016 | ViewPoint Therapeutics | $4.0M Series A | Mark Blumenkranz, Douglas Crawford | Asset Management Ventures, BVF Partners, University of Michigan |
| Feb 9, 2015 | Verana Health | $7.8M Series B | — | Boris Nikolic, GE Ventures, Waycross Ventures |